Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)

v3.24.1.1.u2
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - GBP (£)
Mar. 31, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Accounts payable £ 1,927,612 £ 1,847,279
Other tax and social security 290,255 139,029
Accrued expenses 1,013,162 1,229,419
Amounts accrued in respect to clinical trial testing 1,177,500 1,177,500
Other payables 44,918 38,613
Total £ 4,453,447 £ 4,431,840